EUVIMEDEUVIMED entdecken
Crossref

Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series

James B Doub iD, Aaron J Johnson, Sumon Nandi, Vincent Ng, Theodore Manson, Myounghee Lee, Benjamin Chan

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von James B Doub und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Bacteriophages, Phage Therapy, Arthritis, Infectious. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periprosthetic joint infections are a devastating complication of joint replacement surgery. One novel therapeutic that has potential to change the current treatment paradigm is bacteriophage therapy. Herein, we discuss our experiences with bacteriophage therapy for 10 recalcitrant periprosthetic joint infections and review the treatment protocols utilized to achieve successful outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsBacteriophagesPhage TherapyArthritis, InfectiousHumansAnti-Bacterial AgentsCombined Modality TherapyDebridementTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

Staphylococcusbacteriophage therapydebridement and implant retention surgeryintraarticularperiprosthetic joint infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Orthopedic Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
  • Yale Center for Phage Biology and Therapy, Yale University, New Haven, Connecticut, USA.

ORCID-Profile: James B Doub

Zitieren

APA

Doub, J. B., Johnson, A. J., Nandi, S., Ng, V., Manson, T., Lee, M., & Chan, B. (2023). Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac694

Vancouver

Doub JB, Johnson AJ, Nandi S, Ng V, Manson T, Lee M, et al. Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac694

BibTeX
@article{Doub2023,
  author = {Doub, James B and Johnson, Aaron J and Nandi, Sumon and Ng, Vincent and Manson, Theodore and Lee, Myounghee and Chan, Benjamin},
  title = {Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac694}
}
Kostenlos starten →